Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/1999
06/04/1999CA2253011A1 Dna encoding neospora dihydrofolate reductase-thymidylate synthase
06/03/1999WO1999027138A1 Nucleic acid ligands of tissue target
06/03/1999WO1999027129A1 Virulence-associated nucleic acid sequences and uses thereof
06/03/1999WO1999027128A1 ribH
06/03/1999WO1999027127A1 NOVEL ribB
06/03/1999WO1999027126A1 ribG
06/03/1999WO1999027125A1 ribA
06/03/1999WO1999027121A1 Development of viruses resistant to inactivation by the human complement system
06/03/1999WO1999027117A1 Cold-inducible expression vector
06/03/1999WO1999027110A1 Hormone-dependent forms of the adeno-associated virus, rep proteins, dna sequences coding for them, vectors containing them, and regulatory methods of their intracellular activity
06/03/1999WO1999027109A2 EXTRACELLULAR MATRIX-BINDING PROTEINS FROM $i(STAPHYLOCOCCUS AUREUS)
06/03/1999WO1999027108A1 Lactose repressor proteins with altered ligand responsivity
06/03/1999WO1999027107A2 Gram-positive microorganism formate transporters
06/03/1999WO1999027106A1 NOVEL guaA
06/03/1999WO1999027105A2 Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
06/03/1999WO1999027104A1 Histamine and serotonin binding molecules
06/03/1999WO1999027103A1 Mammalian cytokine-like polypeptide-10
06/03/1999WO1999027102A1 Cd4+ t-lymphocyte protease genes and inhibitors thereof
06/03/1999WO1999027101A1 Method for preparing adenovirus vectors, vectors so prepared, and uses thereof
06/03/1999WO1999027100A1 Fibroblast growth factor-19
06/03/1999WO1999027099A1 Orf, a substrate for extracellular signal-regulated kinase, erk-6, and related methods
06/03/1999WO1999027098A2 A-33 related antigens and their pharmacological uses
06/03/1999WO1999027097A2 CLONING OF A TETRODOTOXIN-RESISTANT SODIUM CHANNEL α-SUBUNIT
06/03/1999WO1999027096A1 A NOVEL EGF MOTIF PROTEIN OBTAINED FROM A cDNA LIBRARY OF FETAL LIVER-SPLEEN
06/03/1999WO1999027095A1 Human cdc10 homolog
06/03/1999WO1999027094A2 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
06/03/1999WO1999027093A2 The nip3 family of proteins
06/03/1999WO1999027092A1 Purified transcription factor cdf-1 and its use
06/03/1999WO1999027091A1 Dp transcription factor-interacting protein and its use
06/03/1999WO1999027090A1 Methods for identifying the toxic/pathologic effect of environmental stimuli on gene transcription
06/03/1999WO1999027089A1 A gene called xlis and the xlis gene product, called doublecortin and their preparations
06/03/1999WO1999027088A2 Novel gene and protein expressed in neural and pancreatic tissues
06/03/1999WO1999027080A2 Human protein kinase and kinase inhibitors
06/03/1999WO1999027079A1 Secreted proteins and polynucleotides encoding them
06/03/1999WO1999027078A1 Chemokine alpha-5
06/03/1999WO1999027075A1 A carboxy-terminal brca1 interacting protein
06/03/1999WO1999027074A1 Novel tig
06/03/1999WO1999026980A1 Methods and reagents for the utilization of sap family member proteins, novel signal transduction regulators
06/03/1999WO1999026979A1 Lactalbumin production process
06/03/1999WO1999026978A1 Signal sequence trapping method
06/03/1999WO1999026977A1 Novel receptors opg-2
06/03/1999WO1999026976A1 Tnf ligand family gene
06/03/1999WO1999026975A2 Method for obtaining biologically active dimers of recombinant human growth factors from the cysteine knot family, use of dimers thus obtained
06/03/1999WO1999026974A1 In vitro and in vivo growth-promoting proteins and peptides for kidney epithelial cells
06/03/1999WO1999026973A1 Secreted proteins and polynucleotides encoding them
06/03/1999WO1999026972A1 Secreted proteins and polynucleotides encoding them
06/03/1999WO1999026971A1 Antimicrobial peptides
06/03/1999WO1999026970A1 NOVEL pth
06/03/1999WO1999026969A1 Zoocin a immunity factor
06/03/1999WO1999026968A1 Oligopeptides and their use as antibacterial agents against staphylococcus strains
06/03/1999WO1999026967A1 Secreted proteins and polynucleotides encoding them
06/03/1999WO1999026966A2 Nuclear receptor ligands and ligand binding domains
06/03/1999WO1999026961A1 Secreted proteins and polynucleotides encoding them
06/03/1999WO1999026960A2 Genes encoding frizzled-like proteins
06/03/1999WO1999026959A1 NOVEL recJ
06/03/1999WO1999026664A1 Recombinant mycoplasma hyopneumoniae vaccine
06/03/1999WO1999026663A2 Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor
06/03/1999WO1999026654A1 Vaccines with an ltb adjuvant
06/03/1999WO1999026653A1 Dna vaccines against tick-borne flaviviruses
06/03/1999WO1999026651A1 ribH
06/03/1999WO1999026650A1 ribB
06/03/1999WO1999026647A1 Use of heparin-binding protein for the modulation or prophylaxis of apoptosis of mammalian cells
06/03/1999WO1999026646A1 ribA
06/03/1999WO1999026645A1 Method of mobilizing hematopoietic stem cells
06/03/1999WO1999026595A1 Keratin-based hydrogel for biomedical applications and method of production
06/03/1999WO1999026570A1 Method of cross-linking keratin-based films, sheets, and bulk materials
06/03/1999WO1999026480A1 Anti-angiogenic gene therapy vectors and their use in treating angiogenesis-related diseases
06/03/1999WO1999026475A1 ribG
06/03/1999WO1999026463A2 Tnf ligand family gene
06/03/1999WO1999019488A9 Novel human egf receptors and use thereof
06/03/1999WO1999016466A3 Vaccine compositions and methods of enhancing vaccine efficacy
06/03/1999WO1999015656A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
06/03/1999WO1999014333A3 Improved method of production of pneumococcal surface proteins
06/03/1999WO1999014242A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
06/03/1999WO1999013077A3 Inducible methods for repressing gene function
06/03/1999WO1999012965A3 April- a novel protein with growth effects
06/03/1999WO1999009166A3 Prostate tumor polynucleotide and antigen compositions
06/03/1999WO1999006565A3 Antifreeze proteins, dna and expression systems
06/03/1999WO1999006552B1 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN BRAIN
06/03/1999WO1999006551B1 5' ESTs FOR SECRETED PROTEINS IDENTIFIED FROM BRAIN TISSUES
06/03/1999WO1999006550B1 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN PROSTATE
06/03/1999WO1999006548B1 5'ESTs FOR NON TISSUE SPECIFIC SECRETED PROTEINS
06/03/1999WO1999003993A3 Suppressors of cytokine signaling; related reagents
06/03/1999WO1998058957A9 Disulfide cross-linked glycoprotein hormone analogs, their preparation and use
06/03/1999WO1998037089A8 Matrix derived anti-hiv peptides and transdominant proteins
06/03/1999CA2641217A1 Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor
06/03/1999CA2314096A1 Nuclear receptor ligands and ligand binding domains
06/03/1999CA2312000A1 Mammalian cytokine-like polypeptide-10
06/03/1999CA2311759A1 Recombinant mycoplasma hyopneumoniae vaccine
06/03/1999CA2311683A1 Secreted proteins and polynucleotides encoding them
06/03/1999CA2311642A1 Method for preparing adenovirus vectors, vectors so prepared, and uses thereof
06/03/1999CA2311237A1 Human proteins having transmembrane domains and dnas encoding these proteins
06/03/1999CA2311235A1 Method of mobilizing hematopoietic stem cells
06/03/1999CA2311170A1 The nip3 family of proteins
06/03/1999CA2311164A1 Nucleic acid ligands of tissue target
06/03/1999CA2310987A1 Tnf ligand family gene
06/03/1999CA2310892A1 Chemokine alpha-5
06/03/1999CA2310621A1 Methods for identifying the toxic/pathologic effect of environmental stimuli on gene transcription
06/03/1999CA2310565A1 Human protein kinase and kinase inhibitors
06/03/1999CA2310561A1 Virulence-associated nucleic acid sequences and uses thereof
1 ... 2278 2279 2280 2281 2282 2283 2284 2285 2286 2287 2288 2289 2290 2291 2292 2293 2294 2295 2296 2297 2298 ... 2916